InsidersTradesSigma
Follow the Grand Pharmaceutical Group Ltd. share price and the full insider trade history of the company, a listed issuer based in Hong Kong. Shares trade on the HK market, under the supervision of HKEX. Operating in the Health Care sector, Grand Pharmaceutical Group Ltd. has logged 3 public disclosures. Market capitalisation: €18.2bn. The latest transaction was reported on 22 April 2026 (Purchase). Among the most active insiders: Tang Weikun. The full history is openly available.
3
Insider Decl.
n/a
Thresholds
€119,833
3 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Grand Pharmaceutical Group Ltd. Strong Buy (bullish), based on 3 analysts. Average price target: HK$11.90.
16Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 9,704 of 28,836 companies
59.6
score / 100
Value58
Quality61
FCF yld0.7%
Earn yld6.7%
EV/EBITDA10.4x
ROE7.4%
Gross mgn55%
Net mgn10%
Debt/EBITDA2.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 22 April 2026
Declarations3 total
50,000 shares@ HK$6.4720.0017% mcap45.0% of flowShareXHKGHKEX:DA20260422E00402
60,000 shares@ HK$6.500.0002% mcap55.0% of flowShareXHKGHKEX:DA20260327E00255
3 of 3 declarations
About Grand Pharmaceutical Group Ltd.
Grand Pharmaceutical Group Ltd. is a company focused on the healthcare and pharmaceutical sector, listed on the Hong Kong Stock Exchange. It specializes in the research, development, and marketing of pharmaceutical products.